The Study
Molecular tracking of insulin resistance and inflammation development on visceral adipose tissue
This study is like building a video game simulation of how cells might behave, based on what other scientists have found. It doesn't test real cells or people — it just guesses what might happen. So we can't say for sure that any of these things actually happen in real life.
Analysis score
Maximum 0 for a computational/algorithm study.
Where the score came from
Your body uses a little bit of inflammation in belly fat to control how much sugar fat cells take in—but when you're obese, this inflammation gets stuck on, and fat cells stop listening to insulin.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 50 / 100
Quality score
Based on clinical experience or non-systematic literature reviews. The lowest level of evidence as they are most susceptible to bias and personal perspective.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes—this explains why diet and exercise help (they reduce inflammation and ceramide), and why anti-inflammatory drugs alone don't cure type 2 diabetes.
- 2In obese people, insulin makes immune cells turn into pro-inflammatory types (Th17 and M1 macrophages) and reduces protective cells (Tregs); insulin resistance only reverses when ceramide inside fat cells is blocked—not just by calming inflammation.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Frontiers in Immunology
Year
2023
Authors
Antonio Bensussen, J. Torres-Magallanes, Elena Roces de Álvarez-Buylla
Related Content
Claims (6)
Fat tissue around internal organs releases signaling molecules that directly reduce the body's ability to respond to insulin.
In people with obesity, ongoing inflammation in fat tissue around internal organs reduces the ability of fat cells to respond to insulin and is linked to higher levels of certain inflammatory immune cells and lower levels of regulatory immune cells.
In lean individuals, insulin triggers a temporary inflammatory response in fat tissue around internal organs to reduce glucose absorption by fat cells, and this is offset by other molecules that suppress inflammation to keep metabolism stable.
In people with obesity and insulin resistance, insulin causes CD4+ T cells to become more pro-inflammatory Th17 cells and fewer regulatory T cells, resulting in ongoing local inflammation.
In fat cells exposed to long-term inflammation, insulin resistance is maintained by signaling molecules inside the cell called ceramides, not by ceramides present outside the cell.
Treating inflammation alone does not restore normal insulin response in fat tissue around organs because the underlying problem involves ceramide signaling that continues to disrupt insulin function.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.